期刊文献+

血小板和淋巴细胞比值联合CA19-9在胆囊癌术后患者预后评估中的价值

Evaluation value of platelet-to-lymphocyte ratio combined with CA19-9 for postoperative prognosis of patients with gallbladder cancer
原文传递
导出
摘要 目的:探讨术前血小板和淋巴细胞比值(PLR)联合CA19-9在胆囊癌患者术后预后评估中的价值。方法:回顾性分析2015年12月至2020年12月华中科技大学同济医学院附属同济医院收治的67例胆囊癌术后患者临床资料。其中男28例,女39例;平均年龄(58±10)岁。患者均签署知情同意书,符合医学伦理学规定。生存分析采用Kaplan-Meier法和Log-rank检验;Cox多因素回归分析影响胆囊癌患者术后预后的独立危险因素;采用ROC曲线下面积(AUC)分析PLR +CA19-9预测胆囊癌患者术后预后的能力。结果:PLR、CA19-9、PLR + CA19-9对胆囊癌患者术后3年总体生存期(OS)预测的ROC曲线分析显示,最佳界值分别为162、38、0.65。Cox多因素回归分析显示,PLR≥162和CA19-9≥38 kU/L是胆囊癌患者术后预后的独立危险因素(HR=3.093,3.852;P<0.05)。低水平和高水平PLR + CA19-9组中位OS分别为43、15个月,差异有统计学意义(χ^(2)=44.342,P<0.05)。PLR预测胆囊癌患者术后1、3年无进展生存期的AUC分别为0.741、0.777,CA19-9相应为0.838、0.780,PLR + CA19-9相应为0.901、0.882。结论:术前PLR联合CA19-9在胆囊癌患者术后预后评估中的预测价值大于PLR或CA19-9单独评估,有一定的临床应用价值。 Objective To evaluate the value of preoperative platelet-to-lymphocyte ratio(PLR)combined with CA19-9 in evaluating postoperative prognosis of patients with gallbladder cancer.Methods Clinical data of 67 patients with gallbladder cancer admitted to Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology from December 2015 to December 2020 were retrospectively analyzed.Among them,28 patients were male and 39 female,aged(58±10)years on average.The informed consents of all patients were obtained and the local ethical committee approval was received.Survival analysis was performed by Kaplan-Meier method and Log-rank test.The independent risk factors of postoperative prognosis of patients with gallbladder cancer were identified by multivariate Cox regression analysis.The efficiency of PLR+CA19-9 for predicting postoperative prognosis of patients with gallbladder cancer was assessed by delineating the area under ROC curve(AUC).Results ROC curve analysis showed that the optimal thresholds of PLR,CA19-9 and PLR+CA19-9 for predicting 3-year overall survival(OS)of patients with gallbladder cancer were 162,38 and 0.65,respectively.Multivariate Cox regression analysis indicated that PLR≥162 and CA19-9≥38 kU/L were the independent risk factors for postoperative prognosis of patients with gallbladder cancer(HR=3.093,3.852;P<0.05).The median OS in the low and high PLR+CA19-9 groups was 43 and 15 months,and the difference was statistically significant(χ^(2)=44.342,P<0.05).The AUC of PLR in predicting postoperative 1-and 3-year progression-free survival of patients with gallbladder cancer was 0.741 and 0.777,0.838 and 0.780 for CA19-9,and 0.901 and 0.882 for PLR+CA19-9,respectively.Conclusions Preoperative PLR combined with CA19-9 has higher value in predicting postoperative prognosis of patients with gallbladder cancer compared with PLR or CA19-9alone,which is of certain value in clinical application.
作者 马振威 朱博 刘赋斌 邓正栋 王剑明 Zhenwei Ma;Bo Zhu;Fubin Liu;Zhengdong Deng;Jianming Wang(Department of Hepatobiliary and Pancreatic Surgery,Tianyou Hospital Affiliated to Wuhan University of Science and Technology,Wuhan 430064,China;Department of Pediatric Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Hepatobiliary and Pancreatic Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处 《中华肝脏外科手术学电子杂志》 CAS 2024年第2期163-168,共6页 Chinese Journal of Hepatic Surgery(Electronic Edition)
基金 国家自然科学基金(81874062,82072730)。
关键词 胆囊癌 血小板 淋巴细胞 血小板和淋巴细胞比值(PLR) CA19-9 预后 Gallbladder cancer Platelet Lymphocytes Platelet-lymphocyte ratio(PLR) CA19-9 Prognosis
  • 相关文献

参考文献7

二级参考文献85

  • 1Yutong He,Di Liang,Daojuan Li,Baoen Shan,Rongshou Zheng,Siwei Zhang,Wenqiang Wei,Jie He.Incidence and mortality of laryngeal cancer in China, 2015[J].Chinese Journal of Cancer Research,2020,32(1):10-17. 被引量:28
  • 2Aikaterini Tsouma,Chrysanthi Aggeli,Panagiotis Lembessis,George N Zografos,Dimitris P Korkolis,Dimitrios Pectasides,Maria Skondra,Nikolaos Pissimissis,Anastasia Tzonou,Michael Koutsilieris.Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients[J].World Journal of Gastroenterology,2010,16(47):5965-5974. 被引量:19
  • 3Lian-Wen Yuan,Dong-Cai Liu,Zhu-Lin Yang.Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2013,12(2):189-195. 被引量:4
  • 4Jemal A, Siegel R, Ward E, et al. Cancer statieties, 2009[J]. CA Cancer J Clin, 2009, 59(4):225 -249.
  • 5Steinberg W. The clinical utility of the CA 19 -9 tumor associateantigen[J]. Am J Gastroenterol, 1990 , 85(4): 350 -355.
  • 6Goonelilleke KS, Siriwardena AK. Systematic review of car-bohy -drate antigen ( CA 19 -9) as a biochemical marker inthe diagnosis of pancreatic cancer [ J ]. Eur J Surg Oncol,2007,33(3) : 266 -270.
  • 7Ballehaninna UK, Chamberlain RS. The clinical utility of ser-um CA19 -9 in the diagnosis, prognosis and management ofpancreatic adenocarcinoma: An evidence based appraisal[J]. J Gastrointest Oncol, 2012,3(2) : 105 -118.
  • 8Waraya M, Yamashita K, Katagiri H, et al. Preoperative ser-um CA19 -9 and dissected peripancreatic tissue margin de-terminers of long - term survival in pancreatie cancer [ J ].Ann Surg Oncol, 2009, 16(5) : 1231 -1240.
  • 9Humphrisi JL, Chang DK, Johns AL, et al. The prognosticand predictive value of serum CA19. 9 in pancreatic cancer[J]. Ann Oncol, 2012,23(7) : 1713 -1722.
  • 10Lamerz R. Role of tumor markers, cytogenetics[J]. AnnOncol, 1999, 10(Suppl4) : 145 -149.

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部